Event-Driven Stocks

Functional Brands Inc.

MEHANasdaq

Healthcare · Medicinal Chemicals & Botanical Products · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 5 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24
Revenue$6.6M$6.6M
Operating income−$1.4M−$229,092
Net income$758,478−$559,356
Total assets$9.1M$7.2M
Total liabilities$7.6M$7.3M
Equity$1.5M−$118,577
EPS (diluted)$0.01$-0.08
Shares out.18.7M6.7M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−21.2%
Net margin
11.5%
Return on equity
49.2%
Return on assets
8.3%
Return on capital (ROCE)
−41.6%
Liabilities / assets
83.1%
Debt / equity
4.91×
Book value / share
$0.08
Revenue growth (YoY)
0.7%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-3.72distress
Accruals / assets
22.3%high accruals
Beneish M-Score
-0.83elevated
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
44
/ 100
Profitability 60Growth 100Catalyst 33Earnings quality 0Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 5 warning● 2 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026638,7921.0-37.9%
Apr 30, 20261.0M1.0+327.1%
Apr 15, 2026240,7541.0-49.5%
Mar 31, 2026476,8451.0+152.2%
Mar 13, 2026189,1001.0-27.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)